These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 8793558)
1. Bone marrow-derived macrophage lines and immortalized cloned macrophage and dendritic cells support priming of Borrelia burgdorferi--specific T cell responses in vitro and/or in vivo. Altenschmidt U; Ricciardi-Castagnoli P; Modolell M; Otto H; Wiesmüller KH; Jung G; Simon MM Immunol Lett; 1996 Apr; 50(1-2):41-9. PubMed ID: 8793558 [TBL] [Abstract][Full Text] [Related]
2. Plasmid DNA and protein vaccination of mice to the outer surface protein A of Borrelia burgdorferi leads to induction of T helper cells with specificity for a major epitope and augmentation of protective IgG antibodies in vivo. Zhong W; Wiesmüller KH; Kramer MD; Wallich R; Simon MM Eur J Immunol; 1996 Nov; 26(11):2749-57. PubMed ID: 8921965 [TBL] [Abstract][Full Text] [Related]
3. The outer surface lipoprotein OspA of Borrelia burgdorferi provides co-stimulatory signals to normal human peripheral CD4+ and CD8+ T lymphocytes. Knigge H; Simon MM; Meuer SC; Kramer MD; Wallich R Eur J Immunol; 1996 Oct; 26(10):2299-303. PubMed ID: 8898937 [TBL] [Abstract][Full Text] [Related]
4. Major histocompatibility complex class II-independent generation of neutralizing antibodies against T-cell-dependent Borrelia burgdorferi antigens presented by dendritic cells: regulation by NK and gammadelta T cells. Mbow ML; Zeidner N; Gilmore RD; Dolan M; Piesman J; Titus RG Infect Immun; 2001 Apr; 69(4):2407-15. PubMed ID: 11254601 [TBL] [Abstract][Full Text] [Related]
5. T helper cell priming of mice to Borrelia burgdorferi OspA leads to induction of protective antibodies following experimental but not tick-borne infection. Zhong W; Gern L; Kramer M; Wallich R; Simon MM Eur J Immunol; 1997 Nov; 27(11):2942-7. PubMed ID: 9394822 [TBL] [Abstract][Full Text] [Related]
6. Protective immunization with plasmid DNA containing the outer surface lipoprotein A gene of Borrelia burgdorferi is independent of an eukaryotic promoter. Simon MM; Gern L; Hauser P; Zhong W; Nielsen PJ; Kramer MD; Brenner C; Wallich R Eur J Immunol; 1996 Dec; 26(12):2831-40. PubMed ID: 8977275 [TBL] [Abstract][Full Text] [Related]
9. The outer surface lipoprotein A of Borrelia burgdorferi provides direct and indirect augmenting/co-stimulatory signals for the activation of CD4+ and CD8+ T cells. Simon MM; Nerz G; Kramer MD; Hurtenbach U; Schaible UE; Wallich R Immunol Lett; 1995 Feb; 45(1-2):137-42. PubMed ID: 7622182 [TBL] [Abstract][Full Text] [Related]
10. Lyme borreliosis in transgenic mice tolerant to Borrelia burgdorferi OspA or B. Fikrig E; Tao H; Chen M; Barthold SW; Flavell RA J Clin Invest; 1995 Oct; 96(4):1706-14. PubMed ID: 7560061 [TBL] [Abstract][Full Text] [Related]
11. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease. Wallich R; Siebers A; Jahraus O; Brenner C; Stehle T; Simon MM Infect Immun; 2001 Apr; 69(4):2130-6. PubMed ID: 11254567 [TBL] [Abstract][Full Text] [Related]
12. Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the cytokine-inducible pathway. Ma Y; Seiler KP; Tai KF; Yang L; Woods M; Weis JJ Infect Immun; 1994 Sep; 62(9):3663-71. PubMed ID: 7520417 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of Borrelia burgdorferi-tick interactions in vivo by outer surface protein A antibody. Pal U; Montgomery RR; Lusitani D; Voet P; Weynants V; Malawista SE; Lobet Y; Fikrig E J Immunol; 2001 Jun; 166(12):7398-403. PubMed ID: 11390491 [TBL] [Abstract][Full Text] [Related]
14. Circumvention of outer surface protein A immunity by host-adapted Borrelia burgdorferi. Barthold SW; Fikrig E; Bockenstedt LK; Persing DH Infect Immun; 1995 Jun; 63(6):2255-61. PubMed ID: 7768606 [TBL] [Abstract][Full Text] [Related]
15. Epitopes on the outer surface protein A of Borrelia burgdorferi recognized by antibodies and T cells of patients with Lyme disease. Shanafelt MC; Anzola J; Soderberg C; Yssel H; Turck CW; Peltz G J Immunol; 1992 Jan; 148(1):218-24. PubMed ID: 1370170 [TBL] [Abstract][Full Text] [Related]
16. Identification of a Borrelia burgdorferi OspA T cell epitope that promotes anti-OspA IgG in mice. Bockenstedt LK; Fikrig E; Barthold SW; Flavell RA; Kantor FS J Immunol; 1996 Dec; 157(12):5496-502. PubMed ID: 8955199 [TBL] [Abstract][Full Text] [Related]
17. Molecular mimicry in Lyme arthritis demonstrated at the single cell level: LFA-1 alpha L is a partial agonist for outer surface protein A-reactive T cells. Trollmo C; Meyer AL; Steere AC; Hafler DA; Huber BT J Immunol; 2001 Apr; 166(8):5286-91. PubMed ID: 11290815 [TBL] [Abstract][Full Text] [Related]
18. Normal human B lymphocytes and mononuclear cells respond to the mitogenic and cytokine-stimulatory activities of Borrelia burgdorferi and its lipoprotein OspA. Tai KF; Ma Y; Weis JJ Infect Immun; 1994 Feb; 62(2):520-8. PubMed ID: 8300210 [TBL] [Abstract][Full Text] [Related]
19. The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi. Golde WT; Burkot TR; Piesman J; Dolan MC; Capiau C; Hauser P; Dequesne G; Lobet Y Vaccine; 1995 Apr; 13(5):435-41. PubMed ID: 7639011 [TBL] [Abstract][Full Text] [Related]
20. Killing of Borrelia burgdorferi by macrophages is dependent on oxygen radicals and nitric oxide and can be enhanced by antibodies to outer surface proteins of the spirochete. Modolell M; Schaible UE; Rittig M; Simon MM Immunol Lett; 1994 May; 40(2):139-46. PubMed ID: 8088871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]